Establishment Labs Holdings EBITDA Margin 2017-2025 | ESTA
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Establishment Labs Holdings (ESTA) over the last 10 years. The current EBITDA margin for Establishment Labs Holdings as of September 30, 2025 is .
| Establishment Labs Holdings EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2025-09-30 | $0.19B | $-0.04B | -22.51% |
| 2025-06-30 | $0.18B | $-0.05B | -29.94% |
| 2025-03-31 | $0.17B | $-0.05B | -28.82% |
| 2024-12-31 | $0.17B | $-0.04B | -25.30% |
| 2024-09-30 | $0.15B | $-0.05B | -30.72% |
| 2024-06-30 | $0.15B | $-0.06B | -36.84% |
| 2024-03-31 | $0.16B | $-0.06B | -38.85% |
| 2023-12-31 | $0.17B | $-0.06B | -36.53% |
| 2023-09-30 | $0.18B | $-0.05B | -29.05% |
| 2023-06-30 | $0.18B | $-0.04B | -23.03% |
| 2023-03-31 | $0.17B | $-0.04B | -22.35% |
| 2022-12-31 | $0.16B | $-0.04B | -21.74% |
| 2022-09-30 | $0.15B | $-0.03B | -19.08% |
| 2022-06-30 | $0.14B | $-0.03B | -20.28% |
| 2022-03-31 | $0.13B | $-0.02B | -16.42% |
| 2021-12-31 | $0.13B | $-0.02B | -15.08% |
| 2021-09-30 | $0.12B | $-0.02B | -15.25% |
| 2021-06-30 | $0.11B | $-0.01B | -9.82% |
| 2021-03-31 | $0.09B | $-0.02B | -18.89% |
| 2020-12-31 | $0.08B | $-0.02B | -27.38% |
| 2020-09-30 | $0.08B | $-0.02B | -25.93% |
| 2020-06-30 | $0.08B | $-0.03B | -33.33% |
| 2020-03-31 | $0.09B | $-0.03B | -29.03% |
| 2019-12-31 | $0.09B | $-0.03B | -31.11% |
| 2019-09-30 | $0.08B | $-0.03B | -40.24% |
| 2019-06-30 | $0.08B | $-0.03B | -40.00% |
| 2019-03-31 | $0.07B | $-0.03B | -40.30% |
| 2018-12-31 | $0.06B | $-0.02B | -34.43% |
| 2018-09-30 | $0.06B | $-0.02B | -29.82% |
| 2018-06-30 | $0.05B | $-0.02B | -35.42% |
| 2018-03-31 | $0.04B | $-0.02B | -37.21% |
| 2017-12-31 | $0.04B | $-0.02B | -51.43% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $2.070B | $0.166B |
| Establishment Labs Holdings Inc. is a medical technology company. It focuses on designing, developing, manufacturing and marketing portfolio of silicone gel-filled breast implants ae well as body shaping implants. The company's brand consists of Motiva Implants(R) and MotivaImagine (R) platform. Its technologies portfolio includes Divina 3D Simulation System(R), Puregraft and MotivaImagine Centers (R). Establishment Labs Holdings Inc. is based in NEW YORK. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $157.813B | 28.64 |
| HCA Healthcare (HCA) | United States | $113.378B | 17.58 |
| CVS Health (CVS) | United States | $95.741B | 11.01 |
| Elevance Health (ELV) | United States | $75.968B | 11.33 |
| Cencora (COR) | United States | $70.528B | 22.74 |
| Natera (NTRA) | United States | $31.966B | 0.00 |
| Labcorp Holdings (LH) | United States | $22.407B | 17.08 |
| DiDi Global (DIDIY) | China | $22.168B | 20.48 |
| Medpace Holdings (MEDP) | United States | $16.568B | 41.13 |
| Viatris (VTRS) | United States | $15.756B | 5.87 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $15.545B | 0.00 |
| ICON (ICLR) | Ireland | $14.422B | 14.31 |
| Solventum (SOLV) | United States | $13.340B | 12.95 |
| BioMerieux (BMXMF) | France | $13.150B | 0.00 |
| CochLear (CHEOY) | Australia | $12.190B | 0.00 |
| Revvity (RVTY) | United States | $12.141B | 21.12 |
| Charles River Laboratories (CRL) | United States | $10.494B | 20.21 |
| Sonic Healthcare (SKHHY) | Australia | $8.046B | 0.00 |
| Avantor (AVTR) | United States | $7.548B | 11.53 |
| HealthEquity (HQY) | United States | $7.439B | 27.82 |
| BrightSpring Health Services (BTSG) | United States | $7.302B | 43.54 |
| Caris Life Sciences,�Inc (CAI) | United States | $6.580B | 0.00 |
| Bausch + Lomb (BLCO) | Canada | $5.940B | 39.00 |
| PACS (PACS) | United States | $5.544B | 33.71 |
| Sotera Health (SHC) | United States | $5.199B | 25.07 |
| Alignment Healthcare (ALHC) | United States | $4.532B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $3.719B | 21.70 |
| GeneDx Holdings (WGS) | United States | $2.862B | 50.26 |
| Concentras Parent (CON) | United States | $2.839B | 17.72 |
| Organon (OGN) | United States | $2.132B | 2.25 |
| Progyny (PGNY) | United States | $2.087B | 41.03 |
| Surgery Partners (SGRY) | United States | $1.914B | 24.67 |
| Pediatrix Medical (MD) | United States | $1.841B | 10.99 |
| Ardent Health (ARDT) | United States | $1.230B | 4.01 |
| Nutex Health (NUTX) | United States | $1.140B | 8.72 |
| CareDx (CDNA) | United States | $1.050B | 17.16 |
| Teladoc Health (TDOC) | United States | $0.953B | 0.00 |
| Omada Health (OMDA) | United States | $0.861B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $0.774B | 12.67 |
| InnovAge Holding (INNV) | United States | $0.773B | 0.00 |
| Embecta (EMBC) | United States | $0.648B | 3.68 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.635B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.616B | 0.00 |
| Enhabit (EHAB) | United States | $0.545B | 24.48 |
| SBC Medicals (SBC) | United States | $0.505B | 9.28 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.497B | 0.00 |
| CryoPort (CYRX) | United States | $0.482B | 0.00 |
| Strata Critical Medical (SRTA) | United States | $0.408B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.391B | 82.38 |
| Auna S.A (AUNA) | Luxembourg | $0.356B | 5.73 |
| Agilon Health (AGL) | United States | $0.343B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.294B | 0.00 |
| So-Young (SY) | China | $0.284B | 0.00 |
| Oncology Institute (TOI) | United States | $0.264B | 0.00 |
| Beauty Health (SKIN) | United States | $0.191B | 0.00 |
| LifeMD (LFMD) | United States | $0.158B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.131B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.107B | 0.00 |
| Biodesix (BDSX) | United States | $0.082B | 0.00 |
| DocGo (DCGO) | United States | $0.076B | 0.00 |
| Park Dental Partners (PARK) | United States | $0.071B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.042B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.042B | 0.00 |
| Pomdoctor - (POM) | China | $0.025B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.020B | 6.03 |
| OSR Holdings (OSRH) | United States | $0.014B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.014B | 0.00 |
| Lifeward (LFWD) | United States | $0.011B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.010B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.010B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.007B | 0.00 | |
| Pheton Holdings (PTHL) | China | $0.006B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| XWELL (XWEL) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |